Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.
Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.
Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.
Submitted by
admin
on August 26, 2017 - 7:41pm
Source:
Yahoo/Zacks.com
News Tags:
Vertex Pharmaceuticals
cystic fibrosis
FDA
priority review
EMA
tezacaftor/ivacaftor
Kalydeco
Headline:
Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.
Do Not Allow Advertisers to Use My Personal information
